Population pharmacokinetic analysis of rimonabant in healthy subjects.

被引：1
|
作者：
Ferron, GM [1 ]
Grandison, M [1 ]
Lockwood, G [1 ]
机构：
[1] Sanofi Aventis, Malvern, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.12.058
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P43 / P43
页数：1
相关论文
共 50 条
  • [1] POPULATION PHARMACOKINETIC ANALYSIS OF LENALIDOMIDE IN HEALTHY KOREAN SUBJECTS.
    Park, J. -S.
    Jeon, J. -Y.
    Jang, K.
    Moon, S.
    Kim, M. -G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S67 - S67
  • [2] POPULATION PHARMACOKINETIC ANALYSIS OF SUMATRIPTAN IN HEALTHY KOREAN MALE SUBJECTS.
    Lee, J.
    Seong, S.
    Park, S.
    Gwon, M.
    Jang, Y.
    Lee, H.
    Yoo, H.
    Yoon, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S76 - S77
  • [3] A population pharmacokinetic analysis for SEP-226330 in healthy subjects.
    Wang, Z.
    Pentikis, H.
    Maier, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S40 - S40
  • [4] Rimonabant pharmacokinetics in healthy and obese subjects.
    Turpault, S
    Kanamaluru, V
    Lockwood, GF
    Bonnet, D
    Newton, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P50 - P50
  • [5] Population pharmacokinetic modeling of ephedrine, norephedrine and caffeine in healthy subjects.
    Csajka, C
    Haller, CA
    Benowitz, NL
    Verotta, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P39 - P39
  • [6] POPULATION PHARMACOKINETIC MODELING OF S-AMLODIPINE IN HEALTHY MALE SUBJECTS.
    Lee, J.
    Park, S.
    Seong, S.
    Han, S.
    Lim, M.
    Park, J.
    Seo, J.
    Lee, H.
    Yoon, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S83 - S83
  • [7] Development and evaluation of a population pharmacokinetic (PK) model for darbepoetin alfa in healthy subjects.
    Kuebler, P
    Lu, J
    Xu, L
    Holmgren, E
    Hambleton, J
    Spyker, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P76 - P76
  • [8] Population pharmacokinetic (PK) modeling of microencapsulated octreotide acetate (MOA) in healthy subjects.
    Zhou, H
    Chen, TL
    Miller, T
    Marino, M
    Lau, H
    McLeod, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 190 - 190
  • [9] Pharmacoignetics of rimonabant in Japanese and caucasian subjects.
    Kanamaluru, Vanaja
    Cabanis, Marie-Jose
    Purkayastha, Jaideep
    Bonnet, Denis
    Lockwood, Graham
    Newton, John
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1204 - 1204
  • [10] Effect of ketoconazole on the temsirolimus pharmacokinetic profile in healthy subjects.
    Shu, C
    Afsharvand, M
    Raible, D
    Zhou, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P34 - P34
12345